Leonard L. Mazur - 14 Aug 2024 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Signature
/s/ Alexander M. Donaldson, by power of attorney
Issuer symbol
CTXR
Transactions as of
14 Aug 2024
Net transactions value
$0
Form type
4
Filing time
27 Sep 2024, 17:26:03 UTC
Previous filing
30 Aug 2024
Next filing
12 Nov 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTXR Common Stock 10,255,343 14 Aug 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Warrant to Purchase Common Stock Disposed to Issuer -3,137,255 -100% 0 14 Aug 2024 Common Stock 3,137,255 $1.15 Direct F1
transaction CTXR Warrant to Purchase Common Stock Award +3,137,255 3,137,255 14 Aug 2024 Common Stock 3,137,255 $1.15 Direct F1
transaction CTXR Warrant to Purchase Common Stock Disposed to Issuer -2,234,700 -100% 0 25 Sep 2024 Common Stock 2,234,700 $0.7700 Direct F2
transaction CTXR Warrant to Purchase Common Stock Award +2,234,700 2,234,700 25 Sep 2024 Common Stock 2,234,700 $0.7700 Direct F2
holding CTXR Warrant to Purchase Common Stock 1,165,048 14 Aug 2024 Common Stock 1,165,048 $1.42 Direct F3
holding CTXR Stock Option (Right to Purchase Common Stock) 550,000 14 Aug 2024 Common Stock 550,000 $0.7000 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 550,000 14 Aug 2024 Common Stock 550,000 $1.25 Direct F5
holding CTXR Stock Option (Right to Purchase Common Stock) 650,000 14 Aug 2024 Common Stock 650,000 $2.04 Direct F6
holding CTXR Stock Option (Right to Purchase Common Stock) 300,000 14 Aug 2024 Common Stock 300,000 $2.00 Direct F7
holding CTXR Stock Option (Right to Purchase Common Stock) 200,000 14 Aug 2024 Common Stock 200,000 $1.01 Direct F7
holding CTXR Stock Option (Right to Purchase Common Stock) 175,000 14 Aug 2024 Common Stock 175,000 $0.6700 Direct F7
holding CTXR Stock Option (Right to Purchase Common Stock) 150,000 14 Aug 2024 Common Stock 150,000 $1.62 Direct F7
holding CTXR Stock Option (Right to Purchase Common Stock) 40,000 14 Aug 2024 Common Stock 40,000 $3.45 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.
F2 The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.
F3 The warrant is fully vested and exercisable immediately.
F4 The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F5 The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F6 The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F7 The options are vested in full and exercisable immediately.